Skip to main content
UCB logo

UCB — Investor Relations & Filings

Ticker · UCB ISIN · BE0003739530 LEI · 2138008J191VLSGY5A09 BR Manufacturing
Open in API
Filings indexed 2,023 across all filing types
Latest filing 2022-03-18 Major Shareholding Noti…
Country BE Belgium
Listing BR UCB

About UCB

https://www.ucb.com/

UCB is a global biopharmaceutical company that focuses on creating solutions for people living with severe diseases, primarily in the fields of neurology and immunology. The company's core activities include the research, development, and commercialization of pharmaceutical and biotechnology products. Guided by a patient-centric and science-driven approach, UCB is committed to innovation and sustainability. Through its UCB Ventures arm, it invests in pioneering technologies and companies with the potential to transform patient care. The company also offers personalized support services to patients and healthcare professionals during their treatment journey with a UCB medicine.

Recent filings

Filing Released Lang Actions
FMR UP ENG.pdf
Major Shareholding Notification Classification · 99% confidence The document is titled 'Transparency notification FMR LLC' and explicitly states it is pursuant to 'Article 14 of the law of 2 May 2007 on the disclosure of large shareholdings.' It details the crossing of the 5% ownership threshold by FMR LLC in UCB SA/NV, including the number of shares held before and after the transaction. This content directly corresponds to regulatory requirements for notifying changes in significant share ownership. This matches the definition for Major Shareholding Notification (MRQ).
2022-03-18 English
FMR UP FR.pdf
Director's Dealing Classification · 98% confidence The document is a 'Notification de transparence' (Transparency Notification) issued by UCB SA, detailing a change in shareholding by FMR LLC. It explicitly mentions that FMR LLC's stake crossed the 5% threshold ('franchi le seuil de 5%') due to an acquisition of voting shares. This type of filing, which reports changes in significant share ownership by external entities crossing regulatory thresholds, directly corresponds to the definition of Major Shareholding Notification (MRQ). Although it is a regulatory filing, MRQ is more specific than the general RNS category.
2022-03-18 French
FMR UP NL.pdf
Major Shareholding Notification Classification · 98% confidence The document is titled "Transparantieverklaring FMR LLC" (Transparency Declaration FMR LLC) and explicitly references Article 14 of the Belgian law of May 2, 2007, regarding the disclosure of major shareholdings. It details the acquisition of UCB shares by FMR LLC, crossing the 5% threshold on March 14, 2022. This content directly corresponds to notifications about changes in significant share ownership levels, which aligns perfectly with the definition for Major Shareholding Notification (MRQ). Although it is a regulatory disclosure, MRQ is the most specific category available for this type of filing, rather than the general RNS.
2022-03-18 Dutch
Own shares - ENG.pdf
Transaction in Own Shares Classification · 99% confidence The document is explicitly titled "Disposal of own shares" and details numerous transactions where UCB disposed of its own shares OTC in connection with the exercise of stock options under its Long-Term Incentive Program. This directly corresponds to the definition of a report concerning the company buying back or selling its own shares. The appropriate filing type code is POS (Transaction in Own Shares). The document is a detailed announcement, not just a notice of publication, so RPA/RNS is less specific.
2022-03-18 English
Own shares - FR.pdf
Transaction in Own Shares Classification · 98% confidence The document is titled "Aliénation d'actions propres" (Alienation of own shares) and details transactions where UCB SA disposed of its own shares following the exercise of options by employees, as required by Belgian Royal Decree (Article 8:6 of the Code des sociétés et associations). This activity specifically relates to the company buying back or issuing its own shares, often tied to employee compensation plans. This directly matches the definition for 'Transaction in Own Shares' (POS), which covers share repurchase/issuance activities.
2022-03-18 French
Own shares - NL.pdf
Transaction in Own Shares Classification · 98% confidence The document is titled "Vervreemding van eigen aandelen" (Disposal of own shares) and details specific transactions where UCB shares were transferred to employees as part of long-term incentive plans (stock options). This activity directly relates to the company managing its own share capital, specifically through the issuance or transfer of shares related to employee compensation schemes. This aligns precisely with the definition of 'Transaction in Own Shares' (POS), which covers share repurchase/issuance activities. The document is a formal announcement (Gereglementeerde informatie) detailing these transactions, not a general regulatory filing (RNS) or a report publication announcement (RPA), as it contains the core data itself.
2022-03-18 Dutch

Browse filings by year

18 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.